Batch release

PROXY can release production batches in all stages of the drug development trajectory. If necessary, PROXY can (re)develop and (re)validate analytical methods, for instance when production batches are upscaled to other contract manufacturers. The major advantage of outsourcing these activities to PROXY isthat consistency is maintained in analytical methodology and results and that costs for analytical transfers and validations are significantly reduced. Several Qualified Persons are available for the certification and release of production batches.